Sarcopenia indicates a loss of skeletal muscle mass, a condition that leads to a decline in
physical performance. In 2018, the European Working Group on Sarcopenia in Older People …

Sarcopenia is a progressive and generalised skeletal muscle disorder involving the
accelerated loss of muscle mass and function that is associated with increased adverse …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

The aging process is characterized by the chronic inflammatory status called
“inflammaging”, which shares major molecular and cellular features with the metabolism …

Sarcopenia is a progressive, generalized skeletal muscle disorder characterized by
reduction of muscle mass and strength. It is associated with increased adverse outcomes …

Recently, sarcopenia has garnered renewed interest. Sarcopenia is a disease characterized
by decreased skeletal muscle mass and strength/function, which can impair the quality of life …

Dual-energy X-ray absorptiometry (DXA) in nowadays considered one of the most versatile
imaging techniques for the evaluation of metabolic bone disorders such as osteoporosis …

The role of body composition in patients with heart failure (HF) has been receiving much
attention in the last few years. Particularly, reduced lean mass (LM), the best surrogate for …

Chronic heart failure (CHF) is frequently associated with the involuntary loss of body weight
and muscle wasting, which can determine the course of the disease and its prognosis. While …

The magnetic field has been proven to enhance bone tissue repair by affecting cell
metabolic behavior. Magnetic nanoparticles are used as biomaterials due to their unique …